Title 16, TITLE 16. HEALTH

Sec. 1. The state department shall meet with representatives of at least the following associations to study and make recommendations on issues concerning Neonatal Abstinence Syndrome (NAS): (1) The Indiana Hospital Association. (2) The Indiana Perinatal Network. (3) The Indiana …

Sec. 2. (a) Before November 1, 2014, the state department, in consultation with the persons described in section 1 of this chapter, shall report the following to the legislative council in an electronic format under IC 5-14-6 for distribution to the appropriate interim study comm…

Sec. 1. (a) This chapter applies to persons and facilities that handle infectious waste, including the following: (1) Hospitals. (2) Ambulatory surgical facilities. (3) Medical laboratories. (4) Diagnostic laboratories. (5) Blood centers. (6) Pharmaceutical companies. (7) Academi…

Sec. 10. (a) The state department may commence an action under IC 4-21.5-3-6 or IC 4-21.5-4 for issuance of an order of compliance and a civil penalty not to exceed one thousand dollars ($1,000) per violation per day against a person who: (1) fails to comply with this chapter or …

Sec. 11. (a) Except as otherwise provided, a person who recklessly violates or fails to comply with this chapter commits a Class B misdemeanor. (b) Each day a violation continues constitutes a separate offense. [Pre-1993 Recodification Citation: 16-1-35-1.] As added by P.L.2-1993…

Sec. 2. (a) As used in this chapter, "contaminated sharp" means an object that meets the following conditions: (1) Is capable of cutting or penetrating the skin. (2) Has been in contact with blood or body fluids. (b) The term includes a hypodermic or suture needle, syringe, scalp…

Sec. 3. (a) As used in this chapter, "effective treatment" means treatment that meets the following conditions: (1) Reduces the pathogenic qualities of infectious waste to a point where the waste is safe to handle. (2) Is designed for the specific waste involved. (3) Is carried o…

Sec. 4. (a) Except as provided in subsections (c) and (d), as used in this chapter, "infectious waste" means waste that epidemiologic evidence indicates is capable of transmitting a serious communicable disease (as set forth in the list published under IC 16-41-2-1). (b) The term…

Sec. 5. As used in this chapter, "pathological waste" includes: (1) tissues; (2) organs; (3) body parts; and (4) blood or body fluids in liquid or semiliquid form; that are removed during surgery, biopsy, or autopsy. The term does not include an aborted fetus or a miscarried fetu…

Sec. 6. As used in this chapter, "secure area" means an area that is designed and maintained to prevent the entry of unauthorized persons. [Pre-1993 Recodification Citation: 16-1-9.7-5.] As added by P.L.2-1993, SEC.24.

Sec. 7. (a) Before infectious waste is placed in an area that is not a secure area and before the waste is sent for final disposal, all infectious waste must be: (1) effectively treated on site; or (2) transported off site for effective treatment; according to rules adopted under…

Sec. 7.5. Any waste that is not infectious waste (as defined in section 4(c) of this chapter) must be double bagged and tied to protect handlers. As added by P.L.146-1996, SEC.7.

Sec. 7.6. (a) This section applies to a person or facility possessing either an aborted fetus or a miscarried fetus. (b) Within ten (10) business days after a miscarriage occurs or an abortion is performed, a person or facility described in subsection (a) shall: (1) conduct the f…

Sec. 8. (a) After consulting with an advisory committee composed of representatives of persons or facilities that handle infectious wastes, the state department shall adopt rules under IC 4-22-2 necessary to carry out this chapter. (b) The state department shall adopt rules under…

Sec. 9. (a) The state department may designate an agent who may enter on private property to inspect for and investigate possible violations of this chapter or rules adopted under this chapter if the following conditions are met: (1) The agent has probable cause to believe that e…

update of plan Sec. 1. (a) The state department shall develop a strategic plan to identify and significantly reduce the prevalence of diabetes and prediabetes in Indiana. (b) In developing the strategic plan under subsection (a), the state department shall collaborate with the of…

Sec. 2. In developing and updating the strategic plan under section 1 of this chapter, the workgroups established under section 1(c) of this chapter shall do the following: (1) Establish baseline benchmarks for diabetes and prediabetes in Indiana using Indiana specific data. (2) …

Sec. 3. Before December 31, 2019, the state department shall deliver a written report to the governor and, in an electronic format under IC 5-14-6, to the general assembly that includes: (1) the strategic plan developed under section 1 of this chapter; and (2) recommendations on …

Sec. 4. This chapter expires July 1, 2026. As added by P.L.33-2018, SEC.1.